Accelerate Diagnostics (LTS:0H8E) Price-to-Operating-Cash-Flow : (As of Dec. 12, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Accelerate Diagnostics Price-to-Operating-Cash-Flow?

As of today (2024-12-12), Accelerate Diagnostics's share price is $1.48. Accelerate Diagnostics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.43. Hence, Accelerate Diagnostics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Accelerate Diagnostics's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Accelerate Diagnostics's highest Price-to-Operating-Cash-Flow Ratio was 342.50. The lowest was 0.00. And the median was 306.25.

LTS:0H8E's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 21.615
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Accelerate Diagnostics's Cash Flow from Operations per share for the three months ended in Sep. 2024 was $-0.12. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.43.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -2.00% per year.

During the past 13 years, Accelerate Diagnostics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.30% per year. The lowest was -145.00% per year. And the median was -15.20% per year.

Accelerate Diagnostics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Accelerate Diagnostics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Price-to-Operating-Cash-Flow Chart

Accelerate Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Accelerate Diagnostics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Accelerate Diagnostics's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Accelerate Diagnostics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerate Diagnostics's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Price-to-Operating-Cash-Flow falls into.

Accelerate Diagnostics Price-to-Operating-Cash-Flow Calculation

Accelerate Diagnostics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.48	/	-1.425
	=

Accelerate Diagnostics's Share Price of today is $1.48.
Accelerate Diagnostics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.43.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Accelerate Diagnostics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerate Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (LTS:0H8E) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

AXDX:USA 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics Headlines

No Headlines